Treatment Information

Back

Brain – Glioblastoma Multiforme treatment details. Chemotherapy.

Azienda Ospedale-Universita , Padova, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:3City/State/Province:Padova
Treatments:ChemotherapyHospital:Azienda Ospedale-Universita
Drugs:Journal:Link
Date:Jan 2002

Description:

Patients: This Phase II study involved 42 patients with recurrent (second relapse) glioblastoma multiforme. All patients had received previous surgery, radiotherapy, and chemotherapy.

Treatment: Treatment consisted of the administration of a chemotherapy drug, temozolomide (temodar).

Toxicity: Toxicities included grade 1-3 leukopenia, grade 1-2 thrombocytopenia, grade 2 gastrointestinal toxicity, and grade 2 hepatic toxicity.

Results: Median survival was 30.3 weeks (7 months).

Correspondence: Alba A. Brandes, MD




Back